BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pollicino T, Caminiti G. HBV-Integration Studies in the Clinic: Role in the Natural History of Infection. Viruses 2021;13:368. [PMID: 33652619 DOI: 10.3390/v13030368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao L, Wang Y, Tian T, Rao X, Dong W, Zhang J, Yang Y, Tao Q, Peng F, Shen C, Wang S, Liu H, Zeng X, Zhou W. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Hepatol Int 2022. [PMID: 36123506 DOI: 10.1007/s12072-022-10419-3] [Reference Citation Analysis]
2 Ghany MG, Lok AS. Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA. Journal of Clinical Investigation 2022;132:e163175. [DOI: 10.1172/jci163175] [Reference Citation Analysis]
3 Salpini R, D’anna S, Benedetti L, Piermatteo L, Gill U, Svicher V, Kennedy PTF. Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. Front Microbiol 2022;13:972687. [DOI: 10.3389/fmicb.2022.972687] [Reference Citation Analysis]
4 Lei B, Song H, Xu F, Wei Q, Wang F, Tan G, Ma H. When does hepatitis B virus meet long-stranded noncoding RNAs? Front Microbiol 2022;13:962186. [DOI: 10.3389/fmicb.2022.962186] [Reference Citation Analysis]
5 Turyadi, Witanto B, El-khobar KE, Parewangi ML, Rasyak MR, Wibowo DP, Thedja MD, Yusuf I, Massi MN, Patellongi I, Syafruddin D, Muljono DH, Fortofoiu M. Host Factors in the Natural History of Chronic Hepatitis B: Role of Genetic Determinants. International Journal of Hepatology 2022;2022:1-10. [DOI: 10.1155/2022/6046677] [Reference Citation Analysis]
6 Zhang Z, Lu W, Huang D, Zhou X, Ding R, Li X, Wang Y, Lin W, Zeng D, Feng Y. Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection. Front Immunol 2022;13:944097. [DOI: 10.3389/fimmu.2022.944097] [Reference Citation Analysis]
7 Linden N, Jones RB. Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses. Trends Immunol 2022:S1471-4906(22)00117-X. [PMID: 35817699 DOI: 10.1016/j.it.2022.06.001] [Reference Citation Analysis]
8 Lok J, Dusheiko G, Carey I, Agarwal K. Review article: Novel biomarkers in hepatitis B infection. Aliment Pharmacol Ther 2022. [PMID: 35770458 DOI: 10.1111/apt.17105] [Reference Citation Analysis]
9 Peña-Asensio J, Calvo H, Miquel J, Sanz-de-Villalobos E, González-Praetorius A, Torralba M, Larrubia JR. Model to predict on-treatment restoration of functional HBV-specific CD8+ cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B. Aliment Pharmacol Ther 2022;55:1545-59. [PMID: 35224746 DOI: 10.1111/apt.16850] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Boettler T, Gill US, Allweiss L, Pollicino T, Tavis JE, Zoulim F. Assessing immunological and virological responses in the liver: implications for the cure of chronic hepatitis B virus infection. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100480] [Reference Citation Analysis]
11 Elbrolosy AM, Elabd NS, ElGedawy GA, Abozeid M, Abdelkreem M, Montaser B, Eed EM, Elhamouly MS. Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients. Clin Exp Med 2022. [PMID: 35119591 DOI: 10.1007/s10238-022-00792-6] [Reference Citation Analysis]
12 Pollicino TERESA. The Impact of Nucleos(t)ide Analogs on Hepatitis B Virus DNA Integration: Hype or Reality? Gastroenterology 2022:S0016-5085(22)00094-4. [PMID: 35120915 DOI: 10.1053/j.gastro.2022.01.039] [Reference Citation Analysis]
13 Erken R, Loukachov V, van Dort K, van den Hurk A, Takkenberg RB, de Niet A, Jansen L, Willemse S, Reesink H, Kootstra N. Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B. Hepatology 2022. [PMID: 35073596 DOI: 10.1002/hep.32352] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
14 Zhang Z, Lu W, Zeng D, Huang D, Lin W, Yan L, Feng Y. Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection. J Clin Med 2021;10:5617. [PMID: 34884319 DOI: 10.3390/jcm10235617] [Reference Citation Analysis]
15 Piermatteo L, Alkhatib M, D'Anna S, Malagnino V, Bertoli A, Andreassi E, Basile E, Iuvara A, De Cristofaro M, Cappiello G, Cerva C, Minichini C, Pisaturo M, Starace M, Coppola N, Fontana C, Grelli S, Ceccherini-Silberstein F, Andreoni M, Gill US, Kennedy PTF, Sarmati L, Salpini R, Svicher V. HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation. Biomedicines 2021;9:1352. [PMID: 34680469 DOI: 10.3390/biomedicines9101352] [Reference Citation Analysis]
16 Tsuge M. The association between hepatocarcinogenesis and intracellular alterations due to hepatitis B virus infection. Liver Int 2021. [PMID: 34559952 DOI: 10.1111/liv.15065] [Reference Citation Analysis]
17 Vachon A, Osiowy C. Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management. Viruses 2021;13:951. [PMID: 34064049 DOI: 10.3390/v13060951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Xu T, Wang P, Zheng X, Yan Z, Li K, Xu J, Jiang C, Zhu F. The therapeutic effects and mechanisms of Long Chai Fang on chronic hepatitis B. Ann Transl Med 2021;9:865. [PMID: 34164499 DOI: 10.21037/atm-21-1923] [Reference Citation Analysis]